The Hydration Pharmaceuticals Co (ASX:HPC) ROE %: -238.33% (As of Dec. 2025)


What is The Hydration Pharmaceuticals Co ROE %?

The Hydration Pharmaceuticals Co ASX:HPC -20.00% ROE % is -238.33% as of Dec. 2025. The stock has 3 warning signs investors should review. Among 306 Retail - Defensive companies, The Hydration Pharmaceuticals Co ranks worse than 99.02% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. The Hydration Pharmaceuticals Co's annualized net income for the quarter that ended in Dec. 2025 was A$-5.78 Mil. The Hydration Pharmaceuticals Co's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was A$2.43 Mil. Therefore, The Hydration Pharmaceuticals Co's annualized ROE % for the quarter that ended in Dec. 2025 was -238.33%.

The historical rank and industry rank for The Hydration Pharmaceuticals Co's ROE % or its related term are showing as below:

ASX:HPC' s ROE % Range Over the Past 10 Years
Min: -451.22   Med: -133.19   Max: 222.03
Current: -141.64

During the past 5 years, The Hydration Pharmaceuticals Co's highest ROE % was 222.03%. The lowest was -451.22%. And the median was -133.19%.

ASX:HPC's ROE % is ranked worse than
99.02% of 306 companies
in the Retail - Defensive industry
Industry Median: 8.53 vs ASX:HPC: -141.64

The Hydration Pharmaceuticals Co  (ASX:HPC) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-5.782/2.426
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-5.782 / 4.44)*(4.44 / 3.623)*(3.623 / 2.426)
=Net Margin %*Asset Turnover*Equity Multiplier
=-130.23 %*1.2255*1.4934
=ROA %*Equity Multiplier
=-159.6 %*1.4934
=-238.33 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-5.782/2.426
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-5.782 / -5.668) * (-5.668 / -6.194) * (-6.194 / 4.44) * (4.44 / 3.623) * (3.623 / 2.426)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0201 * 0.9151 * -139.5 % * 1.2255 * 1.4934
=-238.33 %

Note: The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


The Hydration Pharmaceuticals Co ROE % Related Terms


The Hydration Pharmaceuticals Co ROE % Historical Data

* Premium members only.

The historical data trend for The Hydration Pharmaceuticals Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Hydration Pharmaceuticals Co ROE % Chart

The Hydration Pharmaceuticals Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
-70.92 -133.36 -451.22 222.03 -133.19

The Hydration Pharmaceuticals Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Get a 7-Day Free Trial Premium Member Only 0.00 0.00 1,933.20 -81.98 -238.33

ASX:HPC vs SYY, USFD, PFGC: ROE % Comparison

For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Hydration Pharmaceuticals Co ROE % vs Retail - Defensive Industry

For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's ROE % distribution charts can be found below:

* The bar in red indicates where The Hydration Pharmaceuticals Co's ROE % falls into.



The Hydration Pharmaceuticals Co ROE % Calculation

The Hydration Pharmaceuticals Co's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=-4.306/( (4.33+2.136)/ 2 )
=-4.306/3.233
=-133.19 %

The Hydration Pharmaceuticals Co's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Jun. 2025 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=-5.782/( (2.716+2.136)/ 2 )
=-5.782/2.426
=-238.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -238.33% mean?
The Hydration Pharmaceuticals Co (ASX:HPC) has a ROE % of -238.33% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on The Hydration Pharmaceuticals Co and its competitors. According to the industry distribution chart, The Hydration Pharmaceuticals Co ranks #303 out of 306 companies in the Retail - Defensive industry, placing it in the top 99%.
Is The Hydration Pharmaceuticals Co's ROE % too high?
The Hydration Pharmaceuticals Co's current ROE % is -238.33%. Based on the distribution chart, The Hydration Pharmaceuticals Co ranks #303 out of 306 companies in the Retail - Defensive industry, which is in the bottom quartile relative to peers.
How does The Hydration Pharmaceuticals Co's ROE % compare to SYY and USFD?
According to the Retail - Defensive industry distribution chart, The Hydration Pharmaceuticals Co ranks #303 out of 306 companies for ROE %. This places The Hydration Pharmaceuticals Co in the lower half of its industry. The industry median ROE % is 8.53. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Retail - Defensive company?
The median ROE % among Retail - Defensive companies is 8.53, based on 306 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on The Hydration Pharmaceuticals Co and its competitors. For the Retail - Defensive industry, the median ROE % is 8.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Hydration Pharmaceuticals Co's current ROE % is -238.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current ROE % of -238.33%. The current ROE % is -238.33%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current ROE % is -238.33% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Hydration Pharmaceuticals Co Business Description

Address 6 Palmer Parade, Level 2, Cremorne, Melbourne, VIC, AUS, 3121
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.